3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Precursor Cell Lymphoblastic Leukemia-Lymphoma
20
Burkitt Lymphoma
20
Leukemia, Biphenotypic, Acute
6
Precursor B-Cell Lymphoblastic Leukemia-Lymphoma
4
Recurrence
3
Leukemia
3
Neoplasm, Residual
2
Myelodysplastic Syndromes
1
Lymphoma, Non-Hodgkin
1
Lymphoma, B-Cell
1
Leukemia, Myelomonocytic, Juvenile
1
Leukemia, Myeloid, Acute
1
Leukemia, Myeloid, Accelerated Phase
1
Leukemia, Myeloid
1
Leukemia, Myelogenous, Chronic, BCR-ABL Positive
1
Leukemia, Large Granular Lymphocytic
1
Hodgkin Disease
1
Hematologic Neoplasms
1
Down Syndrome
1
Blast Crisis
1
Interventions
Cyclophosphamide
7
Mycophenolic Acid
6
Tacrolimus
5
Busulfan
4
ruxolitinib
3
fludarabine phosphate
3
fludarabine
3
Whole-Body Irradiation
3
Melphalan
3
Thiotepa
2
Specimen Handling
2
Sirolimus
2
Cyclosporine
2
belumosudil
1
axatilimab
1
Stem Cell Transplantation
1
Peripheral Blood Stem Cell Transplantation
1
Panobinostat
1
Methotrexate
1
Low-Level Light Therapy
1
Leukocyte Count
1
Hematopoietic Stem Cell Transplantation
1
Etoposide
1
Emapalumab
1
Drug Therapy
1
Clofarabine
1
Clinical Trials, Phase I as Topic
1
Biopsy
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Graft vs Host Disease
×
blinatumomab
×
90 days
×
Clear all
No trials found.